October 24, 2024 GeneSight Mental Health Monitor: Special Election Series Phase III Update The latest installment of the GeneSight® Mental Health Monitor: Special Election Series, shows that as Election Day draws closer, Americans’ anxiety and/or depr... Read more
September 17, 2024 GeneSight Mental Health Monitor: Special Election Series Update Americans’ anxiety toward upcoming Presidential election has increased; mental health expert encourages treatment for those who are impacted Phase II of GeneSi... Read more
June 25, 2024 Survey Suggests Increased Attention on Mental Health Warranted in the ... Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election New Findings from Myriad Genetics Reveal One-Third of American... Read more
April 17, 2024 Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to P... 80% of people diagnosed with anxiety, depression report losing years or decades of time SALT LAKE CITY, April 17, 2024 – An astonishing 44% of Americans feel t... Read more
April 9, 2024 Myriad Genetics Research Shows Reduction in Hospitalizations for Pati... Fewer patients were prescribed medications with gene-drug interactions after taking the GeneSight test SALT LAKE CITY, April 9, 2024 – Myriad Genetics, Inc. ... Read more
August 7, 2023 Myriad Genetics Announces Enhancements to the GeneSight® Te... SALT LAKE CITY, Aug. 7 2023 – Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, announced enhancements to the GeneSight® ... Read more